Form 4 for ORGO Organogenesis Holdings Inc.
Accepted 2024-02-20 00:00:00 ET · period of report 2024-02-15 · accession 0001062993-24-003767 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-02-20 | 2024-02-15+ | ORGO | Montecalvo Antonio S. | VP, Health Policy | F - Tax | $3.67 | -10.6K | 127.0K | -8% | -$39.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-02-16 | F | D | 719 | $3.48 | 126,288 | D | — | — | |
| 2 | Common | Class A Common Stock | 2024-02-15 | F | D | 8,657 | $3.68 | 128,259 | D | — | — | |
| 3 | Common | Class A Common Stock | 2024-02-15 | F | D | 1,252 | $3.68 | 127,007 | D | — | — |